Concussion Assessments in Football
Launched by FEDERATION INTERNATIONALE DE FOOTBALL ASSOCIATION · Jan 26, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
1 INTRODUCTION
Concussions represent a subset of traumatic brain injury (TBI), pragmatically described as a "traumatically induced transient disturbance of brain function caused by a complex physiological process". A sports-related concussion (SRC) can result in substantially different outcomes, ranging from no detectable effects to transient functional impairments or even life-threatening complications. While the immediate effects of most concussions are short-lived, typically resolving within days, athletes who continue to play following a concussive event may increase their risk of deve...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female football players from teams in a competition participating in the concussion substitution trial.
- • Players with a current suspected or confirmed concussion.
- • Player assessed by medical personnel proficient in the assessment of concussion symptoms (medical doctor, physiotherapist, or other healthcare professional appropriately certified).
- Exclusion Criteria:
- • - Players less than 18 years of age.
About Federation Internationale De Football Association
The Fédération Internationale de Football Association (FIFA) is the global governing body for soccer, dedicated to promoting the sport and enhancing the health and well-being of players and communities worldwide. Committed to advancing sports science and player safety, FIFA sponsors various clinical trials aimed at understanding the impacts of football on health, optimizing athlete performance, and preventing injuries. By leveraging its extensive network and resources, FIFA fosters innovative research initiatives that contribute to the development of evidence-based practices in sports medicine and athletic training, ultimately ensuring a safer and more effective environment for players at all levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, , United Kingdom
Patients applied
Trial Officials
Andreas Serner, PhD
Principal Investigator
Fédération Internationale de Football Association
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials